Key result
Percutaneous femoral access shows no benefit over surgical cutdown for major vascular complications in tf-TAVI.
Why the study?
Does percutaneous femoral access reduce major vascular complications compared with surgical cutdown in patients undergoing transfemoral transcatheter aortic valve implantation?
Meta-Analysis (n=9,849)
Yes
Does percutaneous femoral access reduce major vascular complications compared with surgical cutdown in patients undergoing transfemoral transcatheter aortic valve implantation?
Percutaneous femoral access during transfemoral TAVI results in similar rates of major vascular complications and hospital length of stay compared to surgical cutdown in anatomically suitable patients at experienced centers.
Answers are grounded in this paper and cite their sources.
Comparable complication rates support either approach in suitable patients; leaves open optimal strategy pending randomized trials.
Objective To compare vascular complications between percutaneous and surgical access during transfemoral transcatheter aortic valve implantation (tf-TAVI) and estimate pooled outcomes following percutaneous access. Design Systematic review and meta-analysis of comparative and single-arm studies. Data sources and review methods PubMed, Embase, and the Cochrane Library were searched from inception to 8 July 2026 (PROSPERO CRD420261454909). Comparative (odds ratio [OR]) and single-arm (pooled proportion) random-effects meta-analyses were performed. Subgroup, meta-regression, sensitivity, and publication-bias analyses were conducted for the primary outcome. Risk of bias was assessed with ROBINS-I, ROBINS-I Single Arm, and RoB 2. Results Ten comparative studies (4 736 patients) and eight single-arm studies (5 113 patients) were included. Major vascular complications did not differ significantly between percutaneous access and surgical cutdown (OR 0.83, 95% CI 0.61-1.14; I2 = 41.8%; 95% prediction interval 0.39-1.78), with no significant differences in secondary clinical outcomes, including hospital length of stay (mean difference -0.96 days, 95% CI -2.38 to 0.47; p = .19). In the single-arm analysis, pooled major vascular complications after percutaneous TAVI were 5.20% (95% CI 3.52-7.63%; 95% prediction interval 1.43-17.21%; I2 = 91.1%), with 30-day mortality of 2.20% (95% CI 1.41-3.40%; 95% prediction interval 0.72-6.46%; I2 = 66.9%). Funnel plot asymmetry (Egger's p = .034) was attributable to a single zero-event study and was not confirmed by the Peters test (p = .651) or after its exclusion (p = .164). Conclusion Percutaneous femoral access was not associated with a statistically significant difference in major vascular complications or other clinically relevant outcomes compared with surgical cutdown in anatomically suitable patients treated at experienced centres; residual confounding cannot be excluded, and this evidence is largely observational and should be considered hypothesis-generating pending confirmation in randomized trials. Registration PROSPERO (CRD420261454909).
No takes yet. Share an insight, caveat, or question.
Coutinho et al. (2026) conducted a meta-analysis in Transfemoral transcatheter aortic valve implantation (tf-TAVI) (n=9,849). Percutaneous femoral access vs. Surgical cutdown was evaluated on Major vascular complications (OR 0.83, 95% CI 0.61-1.14). Percutaneous femoral access did not differ from surgical cutdown for major vascular complications during transfemoral TAVI.
Synapse has enriched 10 related papers. Consider them for comparative context: